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In liver tumors induced by chronic WHV infection in the WHV/woodchuck model of HBV infection, activation of genes of the myc family by
WHV insertion has been well documented. Several studies have shown that N-myc2 is by far the most frequently involved, and in most cases, its
transcriptional activation is due to WHV insertion nearby the gene. N-myc2 has been shown to be also activated by WHV insertion in two
downstream loci, b3n and win. Although the extent of insertion in these latter loci in woodchuck tumors has not been investigated, their discovery
has led to the notion that therein WHV insertion accounts for N-myc2 activation in the remaining tumors expressing the proto-oncogene in absence
of any detectable alteration nearby the gene, a notion remained unproved and not further investigated yet.
In the majority of cases, the above observations were derived from tumors developed in colony born laboratory bred woodchucks
experimentally infected with standardized viral inocula, mostly of the same lineage.
In the present work, we investigated a survey of liver tumors naturally developed in wild woodchucks with naturally acquired chronic WHV
infection. Tumors had histological features of well to moderately differentiated HCCs. In most animals, multiple tumor nodules were observed; in
the great majority of cases, they were shown to be independent tumors because their WHV integration patterns were not clonally related. 53
independent tumors were investigated for N-myc activation and WHV integration nearby N-myc genes and in the b3n and win loci.
Comparison of our results with data from previous studies revealed that, in tumors from naturally infected wild woodchucks, the frequency of
WHV integration nearby N-myc2 has a tendency to be lower and, in addition, N-myc2 activation is due to WHV integration nearby the gene
significantly less frequently than in tumors from experimentally infected colony born animals (12/28, 43% vs. 15/20, 75%, P = 0.0397). These
findings are likely related to the less uniform conditions as to infecting virus and host genetic background in naturally infected wild woodchucks
with respect to experimentally infected colony born woodchucks and suggest that viral and/or host factors may influence the site of viral insertion
finally detected in overt tumors.
In addition, more than one third (11/28, 39%) tumors with activated N-myc2 transcription did not show rearrangement either nearby the gene,
or in b3n or in win. These findings challenge the notion that integration in the downstream b3n and win loci is responsible for N-myc2 activation
in tumors lacking insertion nearby N-myc2 and suggest that in a considerable fraction of liver tumors, at least from wild woodchucks, N-myc2
activation might be due either to WHV integration in further regions of the N-myc2 chromosomal domain or to other mechanisms related or
unrelated to viral insertion.
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Hepatitis B virus (HBV) chronic infection has long been
recognized to be a strong risk factor for development of
hepatocellular carcinoma (HCC) (Beasley et al., 1981). The6) 258 – 269
www.e
Table 1
Woodchucks and liver tumor nodules of the present study
Years of
delivery
Woodchuck Tumors at
autopsy
Tumors
available
1986 W401/86 1 1
1989 W593/89 1 1
W594/89 3 1
W595/89 1 1
W596/89 2 2
W598/89 1 1
W212/89 2 2
1990 W326/90 1 1
1991 W423/91 1 1
W426/91 1 1
1992 W558/92 4 4
W596/92 4 4
W589/92 2 1
1993 W863/93 4 4
W870/93 4 1
W891/93 9 9
W899/93 14 6
1995 W385/95 4 3
W467/95 4 3
W477/95 15 7
W481/95 14 12
1998 W2177/98 3 1
W2231/98 1 1
W2234/98 3 2
Total 24 99 70
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closely related to HBV, and its natural host, the woodchuck
(Marmota monax), are studied as model for HBV infection.
WHV is even more oncogenic than HBV, leading to de-
velopment of hepatocellular carcinoma (HCC) in virtually
100% animals within 1 to 3 years of chronic infection (Popper
et al., 1987).
Almost all HCCs from chronically infected individuals
harbor one to several clonal integrations of viral DNA (Bre´chot
et al., 2000). Hepadnavirus integration at specific loci finally
observed in overt tumors is thought to occur early in tumor
development, according to evidence that random integration
and clonal hepatocyte expansion occur in liver tissue both in
acute WHV infection (Summers et al., 2003) and in chronic
WHV and HBV infection (Mason et al., 2005; Minami et al.,
2005).
In woodchuck HCCs, activation of genes of the myc family
by WHV insertion has been well documented, by far the most
frequently affected being N-myc2, an intronless retro-trans-
posed version of N-myc1. Activation of the N-myc2 gene has
been shown to result from WHV insertion either nearby the
gene (Fourel et al., 1990; Hansen et al., 1993; Wei et al., 1992)
or in the b3n and win downstream loci, located about 10 kb and
150 kb from the gene, respectively (Bruni et al., 1999; Fourel et
al., 1994). S/MAR elements detected in b3n and win might
mediate long-range activation of N-myc2 by WHV insertion in
these loci (Bruni et al., 2004; D’Ugo et al., 1998).
Data about WHV insertion nearby N-myc1 or N-myc2 in
woodchuck liver tumors have been so far reported in four
studies (Fourel et al., 1990; Hansen et al., 1993; Jacob et al.,
2004; Wei et al., 1992) and in three of them N-myc2
transcriptional activation has been analyzed too (Fourel et al.,
1990; Hansen et al., 1993; Wei et al., 1992).
Examination of the origin of woodchucks and mode of
infection in these four studies shows that data from naturally
infected wild woodchucks have been reported only for 5
tumors from 5 animals (Wei et al., 1992): most available data
about WHV integrations nearby N-myc genes in woodchuck
liver tumors were obtained from colony born laboratory bred
woodchucks experimentally infected as newborns with stan-
dardized viral inocula, mostly of the same lineage (Hansen et
al., 1993; Jacob et al., 2004; Wei et al., 1992) and, at lower
extent, from woodchucks whose origin and mode of infection
were not reported (Fourel et al., 1990). Thus, an unsolved issue
is whether or not the observed frequent WHV insertion nearby
N-myc2 and frequent N-myc2 activation in woodchuck HCC
may have been influenced by the experimental settings, i.e., the
use of standardized viral inocula and colony born woodchucks.
Differently from WHV insertion nearby N-myc genes,
systematic screening of large HCC surveys for WHV insertions
in the b3n and win loci has not been reported. WHV integration
in the b3n locus has been so far reported in three individual
liver tumors only (Bruni et al., 1995a, 2002; Yamazoe et al.,
1991). The win locus was identified as a target of WHV
integration by analyzing a small group of 13 tumors in which
N-myc2 transcription was activated in absence of any
detectable alteration of the gene (Fourel et al., 1994). SixWHV insertions from 6 tumors were shown to cluster in a 16
kb SacI genomic fragment from win.
The discovery of the b3n and win recurrent targets has led to
the notion that WHV insertion in these loci would account for
N-myc2 activation in those woodchuck liver tumors character-
ized by active N-myc2 transcription in absence of any
detectable alteration of the gene, a notion that has remained
unproved and not further investigated yet.
In order both to evaluate if this notion is correct and to get
more insights into the possible influence of animal origin and
mode of infection on frequency of WHV insertion nearby N-
myc2 and activation of this gene, in the present work, we
studied a survey of liver tumors naturally developed in wild
woodchucks with naturally acquired chronic WHV infection.
In our knowledge, no tumor surveys, either from naturally or
from experimentally infected woodchucks, have been so far
systematically investigated for N-myc activation as well as
rearrangement and WHV integration in all known target
regions (N-myc1, N-myc2, b3n, and win) involved in acti-
vation of N-myc genes.
Results
Liver tumor nodules were collected at autopsy from 24
wild-caught woodchucks with chronic WHV infection acquired
by natural routes. Although a single nodule was observed in 8/
24 woodchucks, multifocal HCC largely prevailed, occurring
in 16/24 animals. Two, three, and four nodules were observed
in 3/24, 3/24, and 6/24 animals, respectively, and more than
four nodules (up to 15) in 4/24 animals (Table 1). 70 tumors
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nodules ranged from 5 mm to 60 mm in diameter, most of them
being 10 to 30 mm.
Nodules were confirmed to be HCCs by examination of
histological sections of a tumor fragment and adjacent non-
tumor liver tissue.
Non-tumor tissue surrounding tumor nodules frequently
showed areas of confluent necrosis, while more distal liver
parenchyma showed morphological features compatible with a
low degree viral infection (mild portal inflammation, occa-
sional lobular activity, rare focal steatosis, mostly of the
macrovesicular type) (Fig. 1A). According to previous reports,
no evidence of significant fibrosis or cirrhosis was observed in
any non-neoplastic samples.
All examined tumor specimens showed similar architecture,
mostly of the trabecular type, with similar cytological features:
on the whole, they appeared as well-differentiated tumors
showing grade 1 features, according to the Edmonson and
Steiner (1954) classification (Fig. 1B). No significant hepato-
cyte polymorphism was observed, except for small focal less
well-differentiated areas that could be classified as moderatelyFig. 1. Photomicrographs of tumor and non-tumor liver sections, stained with
hematoxylin–eosin. HCC grading according to Edmonson and Steiner, 1954.
Magnification: 250. (A) Non-neoplastic liver tissue. (B) A well-differentiated
HCC, grade 1, showing well-differentiated hepatocytes with normal nuclear to
cytoplasm ratio, no significant polymorphism, homogeneous appearance,
irregular distribution, and trabecular architecture. (C) A moderately differen-
tiated, grade 2, focal area. Cells still show hepatocyte morphological features,
but with appreciable polymorphism and polymorphic size, diffuse distribution,
signs of apoptosis and, sometimes, well visible nucleoli and abnormal nuclei.differentiated focal grade 2 areas (Fig. 1C). On average, cells in
focal grade 2 areas were smaller than normal hepatocytes, with
rounded and prominent nuclei and, frequently, well visible
nucleoli. These cells contained usually little eosinophilic
cytoplasm with ill-defined borders. Giant neoplastic cells and
significant pleomorphism were only occasionally observed.
Mitoses were rare and, usually, with no atypical features;
bizarre mitosis were never observed. Vesicles and/or lipid
vacuoles were observed in many hepatocytes. Neoplastic tissue
was frequently associated to different degrees of necrosis and
hemorrhage and, sometimes, to mild inflammation and fibrosis.
WHV DNA integration and clonality of liver tumor nodules in
multifocal HCCs
A fragment from all 70 tumor tissues as well as a fragment
from non-neoplastic liver tissue from each animal were
subjected to DNA extraction. WHV DNA integration was
evaluated by hybridization with WHV probe of total DNA
from tumor and corresponding non-tumor tissues, cleaved with
enzymes cutting WHV genome once (HindIII, BglII, EcoRI,
SacI). Abundant replicative intermediates were observed in all
normal liver samples; remnants of viral replication were also
observed in tumor tissues, although at variable but usually
lower levels than in normal liver tissue (examples are reported
in Fig. 3, in the panels showing hybridization with WHV
probe). Detection of hybridizing DNA fragments with size
higher than full-length linear 3.3-kb WHV genome with at least
two different restriction enzymes was considered evidence for
WHV DNA integration.
Comparison of viral integration patterns has been used
previously as a molecular marker to establish the possible
clonal origin of multiple liver nodules. An identical integration
pattern provides evidence for clonal relationships among
different nodules.
Nodules from animals showing at least two nodular lesions
were analyzed for WHV integration pattern. Analysis of
available nodules from animals with up to 4 nodules did not
show evidence for clonality; in contrast, evidence for clonal
nodules was obtained in three out of four animals showing a
number of tumor nodules at autopsy far above the average
(W891/93, W477/95, W481/95, harboring 9 to 15 total
nodules, see Table 1). In particular, in W891/93 and W477/
95, all analyzed nodules (nine and seven nodules, respectively)
showed common WHV integration patterns and, thus, were
considered to be clonally derived from a primary tumor. In
W481/95, only four out of twelve tumors showed a common
WHV integration pattern; each of the remaining eight nodules
showed independent patterns and was included in the group of
independent tumors to be further analyzed.
Based on this analysis, 53 tumors from 24 animals,
including one representative tumor of each clonal group, out
of 70 analyzed nodules were considered to be independent and
further studied.
WHV DNA integration was clearly detected in 48/53 (91%)
independent tumors; the presence of integrated WHV DNA
could not be established in 2/53 tumors (W596/89-T1 and
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replicative intermediates (data not shown).
Analysis of tissue DNA for rearrangement and WHV
integration in N-myc1, N-myc2, b3n and win loci
All tumor and corresponding non-neoplastic liver DNA
samples were analyzed for rearrangement and/or WHV
integration in or close to N-myc1 and N-myc2 genes, as well
as in the b3n locus; all tumors found to be negative for
rearrangements and/or WHV integration in any of these regions
but positive for N-myc2 transcriptional activation by Northern
blotting (see next paragraph), as well as both several randomly
chosen samples positive for rearrangement in N-myc2 and
several randomly chosen samples negative for N-myc2
transcription, were also analyzed for rearrangements and/or
WHV integration in the win locus.
Detection of abnormal fragments in tumor DNA in addition
to the fragments observed in non-neoplastic tissue was
interpreted as rearrangement of the probed region; if abnormal
fragments co-hybridized with the WHV probe, rearrangement
was considered to be due to WHV integration.
Fig. 2 reports the partial restriction map of the analyzed
regions as well the probes used for hybridization. In order to
make our results comparable with data from previous studies,
suitable genomic restriction fragments analyzed in previous
reports were investigated.Fig. 2. Partial restriction maps of the N-myc2, b3n, and win regions (A) and N-myc1
in the present study (5VN-myc, N-mycGR, b3n, E850s, SpInt1) are positioned above
probes co-hybridize with fragments from both N-myc1 and N-myc2, although with d
genes. Probe regions completely or strongly homologous with correspondent genom
The normal genomic restriction fragments detected by each probe are shown, and th
are reported as ex1, ex2, and ex3.Analysis of N-myc genes was previously carried out with
different restriction approaches. In two studies, multiple
digestions/hybridizations finally resulted in the screening of a
15 kb- to +13-kb genomic region surrounding the N-myc2
transcriptional start site (cumulative data from Fourel et al.,
1990; Wei et al., 1992); however, all identified N-myc2
rearrangements were actually clustered within 3 kb and +3
kb around N-myc2 transcriptional start site, i.e., a region
included in the BglII genomic fragments from N-myc2
analyzed in the subsequent study by Hansen et al. (1993). In
Jacob et al. (2004), analysis of N-myc genes was carried out by
HindIII digestion, likely resulting in underestimation of total
N-myc rearrangements because excluding an important clus-
tering region of WHV integration located at 3 kb to 2 kb
from the 5V end of N-myc2 (Wei et al., 1992; see also Fig. 2A);
in addition, it was not assessed if rearrangements involved N-
myc1 or N-myc2.
In order to compare rigorously data from the present study
with data from previous reports, all liver and tumor samples
from our survey were analyzed for rearrangement of N-myc
genes both by HindIII digestion (to obtain data comparable
with data from Jacob et al., 2004) and by BglII digestion (to
obtain data comparable with data from the other studies). In
the BglII approach, as in previous studies, it was also
determined if rearrangements involved N-myc1 or N-myc2
and if WHV integrations were 5V or 3V with respect to the N-
myc2 gene.region (B) analyzed for rearrangement and WHV integration. The probes used
the corresponding homologous genomic regions. The 5VN-myc and N-mycGR
ifferent affinity because of sequence and structure differences between the two
ic regions are reported as a black bar, regions with no homology as an open bar.
eir size in kb is indicated. B: BglII; E: EcoRI; S: SacI. The three N-myc1 exons
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producing a 3.5-kb fragment from N-myc2 and a 7.4-kb
fragment from N-myc1 (Fig. 2). HindIII digested DNA was
hybridized sequentially with the N-mycGR and WHV probes.
Fig. 3A reports a representative example of Southern blotting
results. Rearranged fragments were detected in W899T1 and
W899T2 by the N-mycGR probe (Fig. 3A): both fragments co-
hybridized with the WHV probe, evidence for WHV insertion
nearby N-myc genes.
BglII separates the N-myc2 gene into two fragments (Fig.
2A): a 5.5-kb fragment, spanning the 5V end of the gene as well
as about 5 kb of upstream DNA, detected by the 5VN-myc
probe, and a 4.8-kb fragment, spanning most of the coding
region as well as the 3V end, detected by the N-mycGR probe. A
representative example of Southern blotting analysis of N-myc
genes by BglII digestion is reported in Fig. 3B. According to
hybridization of abnormal fragments to either 5VN-myc or N-
mycGR, WHV integrations and/or rearrangements were
mapped to the 5V or 3V regions of the N-myc2 gene. In the
example of Fig. 3B, a rearranged fragment was detected in
W899T1 by the 5VN-myc probe and in W899T2 by the N-
mycGR probe; both fragments co-hybridized with the WHV
probe. In these tumors, no additional fragments hybridized with
the SpInt1 probe, specific for N-myc1, proving that rearrange-Fig. 3. Southern blotting analysis of total DNA from some liver and tumor tissues fo
win (D). (A) Hybridization of HindIII digested DNA samples from W899/93 wit
samples from W594/89, W899/93, and W589/92 with the 5VN-myc, N-mycGR, SpIn
W594/89 and W899/93 with the b3n and WHV probes. (D) Hybridization of SacI d
probes. The hybridized probe is reported on the right side of each panel. Open arrow
The size (kb) of some reference fragments is reported.ments involved N-myc2. Thus, W899T1 and W899T2 harbor
WHV integrations located, respectively, 5V and 3V of the N-
myc2 gene.
BglII also produces a unique 9.2-kb fragment containing the
entire N-myc1 gene (Fig. 2B), detected by both the 5VN-myc
and the N-mycGR probes, as well as by the SpInt1 probe,
specific for N-myc1. In Fig. 3B, W589TA showed an
additional BglII fragment co-hybridizing with 5VN-myc, N-
mycGR, SpInt1, and WHV probes, consistent with a WHV
insertion involving N-myc1.
The b3n region was analyzed by EcoRI digestion and
hybridization first with the b3n probe, that detects a 4.3-kb
fragment in normal woodchuck liver DNA, according to a
previous report (Bruni et al., 1999), and then with the WHV
probe. A representative example is shown in Fig. 3C.
Rearranged fragments detected inW594T and W899T7 by the
b3n probe also co-hybridized with the WHV probe, evidence
for WHV insertion in the b3n locus. Molecular characterization
of WHV integrations in these tumors was already reported in
detail (Bruni et al., 1995a, 2002). An additional fragment is
also visible in W899T4, but it proved to be a partial digestion
product because it did not hybridized with the WHV probe and
was no more detected by the b3n probe in further hybridization
experiments (data not shown).r rearrangements and WHV integration in N-myc genes (A and B), b3n (C) and
h the N-mycGR and WHV probes. (B) Hybridization of BglII digested DNA
t1, and WHV probes. (C) Hybridization of EcoRI digested DNA samples from
igested DNA samples from W870/93 and W899/93 with the E850s and WHV
heads show rearranged fragments co-hybridizing with the WHVor other probes.
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hybridization first with the E850s probe, that detects a 16-kb
fragment in normal woodchuck liver DNA, according to a
previous report (Fourel et al., 1994), and then with the WHV
probe. In the representative example shown in Fig. 3D, a
rearranged fragment was detected by E850s probe in W899T4;
this fragment co-hybridized with the WHV probe, evidence for
WHV insertion in win.
Detailed results of Southern analysis of tumors found to be
positive for either rearrangement in any of the assayed genomic
regions or N-myc2 transcriptional activation (see next para-
graph) or both are reported in Table 2, together with Northern
blotting data. Evidence for rearrangement of N-myc genes,Table 2
Southern and Northern blotting data of liver tumors positive for either rearrangemen
both
Woodchuck Tumors Additional fragments by Southern blottinga
5VN-myc N-mycGR SpInt1
BglII HindIII BglII BglII
W401/86 T + +  
W212/89 T1  + + 
T2    
W594/89 T1    
W598/89 T  + + 
W326/90 T  + + 
W423/91 T + +  
W426/91 TA  + + 
W558/92 T1    
T2    
T3    
T4    
W589/92 TA +  + +
W596/92 T2 + +  
W863/93 TA +c   
TC +   
TD +   
W870/93 TA    
W899/93 T1 + +  
T2  + + 
T4    
T5    
T6    
T7    
W385/95 T1  + + 
T2 +   
T4    
W467/95 T2 +   
T3    
T4 +c   
W477/95 T + + + 
W481/95 T2    
T6    
T8 + +  
W2177/98 T3  + + 
+ and  refer to presence (+) or absence () of either additional fragment(s) in So
n.c.—not carried out.
n.a.—tissue not available for RNA extraction.
a All detected additional fragments co-hybridized with the WHV probe, except th
b Rearrangements were due to WHV integration, except those marked by d.
c Additional fragments that did not co-hybridized with the WHV probe.
d Rearrangement not due to WHV integration.
e Transcripts co-hybridizing with the WHV probe.
f Unassigned to either 5V or 3V because of a complex rearrangement involving virwith or without WHV insertion, was observed in 20/53 (38%)
tumors. N-myc1 was found to be an infrequent target of WHV
insertion, being involved only in 1/53 tumors (<2%). Rearran-
gements involved mainly the N-myc2 gene and, in most cases,
were due to WHV insertion nearby the gene (17/53 tumors,
32%); in nine tumors, viral DNAwas located 5V of the gene and
in seven tumors in the 3V region; in one tumor, it was not
possible to establish conclusively the 5V or 3V location of viral
DNA because results of Southern analysis suggested a complex
rearrangement involving viral and cellular sequences (Table 2:
W477/95-T). Rearrangement 5V of N-myc2 without WHV
insertion was observed in two tumors (Table 2: W863/93-TA
and W467/95-T4). Rearrangements of the b3n and win locit in N-myc1, N-myc2, b3n or win loci or N-myc2 transcriptional activation or
Rearranged locusb N-myc2 transcriptiona
b3n E850s
EcoRI SacI
  N-myc2 (5V) + (both 2.3 kb and >2.3 kb)
  N-myc2 (3V) n.a.
 + win n.a.
+ n.c. b3n +
 n.c. N-myc2 (3V) n.a.
 n.c. N-myc2 (3V) + (>2.3 kb)
 n.c. N-myc2 (5V) +
 n.c. N-myc2 (3V) + (>2.3 kb)
  None +
  None +
  None +
  None +
 n.c. N-myc1 n.a.
  N-myc2 (5V) n.a.
  N-myc2 (5V)d +
  N-myc2 (5V) n.a.
  N-myc2 (5V) n.a.
  None +
 n.c. N-myc2 (5V) +
 n.c. N-myc2 (3V) + (>2.3 kb)e
 + win +
  None +
  None +
+ n.c. b3n +
  N-myc2 (3V) + (>2.3 kb)
  N-myc2 (5V) +
  None +
  N-myc2 (5V) +
  None +
  N-myc2 (5V)d +
  N-myc2f + (>2.3 kb)
  None +
  None +
 n.c. N-myc2 (5V) +
  N-myc2 (3V) + (>2.3 kb)e
uthern blotting or abundant N-myc2 transcription in Northern blotting.
ose marked by c.
al and cellular sequences.
Table 3
Data about N-myc rearrangement and N-myc2 activation obtained in the present study compared with data from previous studies
Tumor survey Infection
mode
Animals Tumors Tumors with rearrangement in N-myc genes Tumors with N-myc2 activation
Total WHV integration only Total With WHV integration
nearby N-myc2
Nearby N-myc1 Nearby N-myc2
Present study Natural 24 53 20/53 (38%) 1/53 (2%) 17/53 (32%) 28/40 (70%) 12/28 (43%)
Fourel et al., 1990a n.r. n.r. 30 10/30 (33%) 1/30 (3%) 8/30 (27%) 18/30 (60%) 8/18 (44%)
Wei et al., 1992 Natural 5 5 3/5 (60%) 0/5 3/5 (60%) 4/5 (80%) 3/4 (75%)
exp. 7 14 10/14 (71%) 0/14 10/14 (71%) 11/14 (79%) 10/11 (91%)
Hansen et al., 1993 exp. 7 17 7/17 (41%) 1/17 (6%) 6/17 (35%) 9/12 (75%)b 5/9 (55%)
Jacob et al., 2004 exp. 13 55c 23/55 (42%)d 21/55 (38%)d n.r. n.r.
Cumulative data from
experimentally infected
woodchuckse
exp. 14 31 17/31 (55%) 1/31 (3%) 16/31 (52%) 20/26 (77%) 15/20 (75%)
n.r.—not reported.
exp.—experimental.
a Some data from this tumor survey were reported in Wei et al., 1992, due to analysis of a further region upstream of N-myc2.
b Actually, 13 tumors were analyzed for N-myc transcription, but 1 tumor showed evidence of extensive RNA degradation and, thus, was not included; in addition,
although 10 tumors showed N-myc activation, in 1 of them transcripts were most likely from N-myc1, because in that tumor WHV integration was demonstrated to
involve N-myc1, not N-myc2 and, thus, was not included in the group of tumors with N-myc2 activation.
c 51 out of 55 tumors were found to be HCCs, the remaining 4 tumors were adenomas.
d Search for N-myc rearrangements was carried out by HindIII digestion only, limiting analysis to smaller N-myc genomic regions than other previous studies and
excluding a region upstream of N-myc2 shown to be frequently targeted by WHV integration. In addition, the used approach did not distinguish if rearrangements
involved N-myc1 or N-myc2.
e Only tumors with both DNA and RNA analysis, cumulative data from Wei et al., 1992 and Hansen et al., 1993.
Fig. 4. Northern blotting analysis of total RNA from normal liver and tumo
tissues for transcriptional activation of N-myc genes. Filters were hybridized
sequentially to the N-mycGR probe (A), the WHV probe (B) and, finally, the
h-actin probe (C) to control for total RNA loading. Open arrowheads indicate
transcripts co-hybridizing with both N-mycGR and WHV probes. In live
tissues, WHV probe detected high levels of two major transcripts, whose size
is consistent with the 3.7 kb and 2.3 kb major viral RNAs previously
described in liver tissue of WHV infected woodchucks (Fourel et al., 1990
Buendia, 1992 and references therein); in tumor tissues, the level of these
transcripts was highly variable being reduced or absent in some samples and
abundant in others.
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tumors each locus, 4%) and were caused by WHV insertion in
all 4 tumors.
On the whole, rearrangement, with or without WHV
insertion, in any known loci of the N-myc2 chromosomal
domain was observed in 23/53 tumors (43%), and in 21 of
them was due to WHV integration.
Data about N-myc rearrangement are further summarized
and compared to data from previous studies in Table 3.
Analysis of tissue RNA for N-myc transcriptional activation
Enough and suitable tissue was available to analyze RNA too
by Northern blotting in 40/53 independent HCCs and
corresponding normal liver. A representative example is shown
in Fig. 4. N-myc transcripts of variable size were detected in all
shown tumor samples by the N-mycGR probe that detects both
N-myc1 and N-myc2 sequences (Fig. 4A). In tumors W594/89-
T, W863/93-TA, W870/93-TA, and W899/93-T1, the 2.3-kb
size of the transcript is consistent with the size of the
transcription product from the normal promoter of N-myc2 gene
(Wei et al., 1992). In tumors W326/90-T, W477/95-T1, and
W899/93-T2, one or two transcripts with higher size were
present. In order to assess if any transcripts, in particular, those
ones larger than 2.3 kb, could be N-myc1 transcripts or N-myc/
WHV fusion transcripts or aberrant over-sized N-myc2 tran-
scripts, all filters were sequentially hybridized first with the
SpInt1 probe, specific for N-myc1, and then with the WHV
probe. No transcripts hybridized with the SpInt1 probe, specific
for N-myc1, suggesting that all of them had been produced from
N-myc2 (data not shown). In W899/93-T2, the N-myc transcript
co-hybridized with the WHV probe (Fig. 4B), suggesting a
WHV/N-myc2 fusion transcript. This result was consistent withSouthern blotting data, showing in this tumor WHV insertion in
the 3V region of N-myc2 (Fig. 3B and Table 2).
Results of Northern blotting analysis of all tumors showing
N-myc2 activation are included in Table 2. Results are furtherr
r
;
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Table 3.
On the whole, abundant N-myc2 transcripts were detected in
28/40 (70%) tumors. A single 2.3-kb transcript was detected in
21/28 tumors, while one or two transcripts of heterogeneous
size, but exceeding 2.3 kb, were observed in 6/28; one tumor
showed both the 2.3 kb and a larger transcript (Table 2: W401/
86-T). Co-hybridization with the WHV probe, suggesting
WHV/N-myc2 fusion transcripts, was observed for transcripts
exceeding 2.3 kb from only two tumors (Table 2: W899/93-T2
and W2177/98-T3). These results suggest that transcripts
exceeding 2.3 kb detected in the remaining five tumors were
more likely products of aberrant transcription, due to either
usage of upstream unusual start sites or termination at an
alternative downstream site.
Correlation between N-myc2 activation and WHV integration
in target regions of N-myc2 chromosomal domain
Transcriptional activation of N-myc2 could be related to
WHV integration in or close to N-myc2, or in b3n or in win in
12/28 (43%), 2/28 (7%), and 1/28 (<4%) tumors, respectively,
while in 2/28 (7%) tumors N-myc2 activation was related to
rearrangements in the 5V region of the gene without WHV
insertion. Thus, on the whole, N-myc2 transcriptional activa-
tion was associated to WHV integration and/or rearrangement
in known target regions of the N-myc2 chromosomal domain in
17/28 (61%) tumors. In the remaining 11/28 (39%) tumors with
N-myc2 activation, no evidence for WHV insertion or
rearrangement in the assayed N-myc2, b3n, or win regions
was obtained. The possibility that these results may be due to
low or variable sensitivity of Southern blotting/hybridization
experiments was excluded because the expected fragments
from normal un-rearranged alleles, providing internal control of
the entire procedure for each sample, were clearly detected in
all tested samples (for an example, see Fig. 3). Remarkably, all
tumors with N-myc2 activation but no N-myc2, b3n, and win
rearrangement had evidence of WHV-DNA integrated some-
where into the host genome, and in all of them, the size of N-
myc2 transcripts was 2.3 kb as expected for normal transcrip-
tion from the N-myc2 gene (Table 2).
Discussion
According to most previous estimates in both human and
woodchuck HCC induced by HBV and WHV, respectively, the
great majority of examined tumors of the present study showed
evidence of WHV integration into cellular DNA (48/53 tumors,
91%). Although in two tumors WHV integration could not be
evaluated, three tumors appeared to be devoid of any detectable
viral insertion. It cannot be excluded that in these latter tumors,
integrated WHV may be very small, below the detection limit
of the Southern blotting/hybridization method because provid-
ing a too short target for hybridization. Alternatively, in these
tumors, WHV insertion might have been lost during tumor
outgrowth because of recombination events, as previously
proposed for HBV too.A careful review of past literature has shown that most data
about WHV insertions activating N-myc genes in woodchuck
liver tumors had been obtained from colony born laboratory
bred woodchucks experimentally infected as newborns by
standard inocula, mostly of the same lineage (WHV7 or its
derivative passage WHV7P1). In a first study, 14 liver tumors
had been collected from 7 woodchucks experimentally
inoculated with either of two standardized pools of WHV-
positive sera (WHV7 and WHV9) (Wei et al., 1992, referring
to Popper et al., 1987 for details about experimental infection);
in another study, 17 analyzed tumors were collected from 7
woodchucks experimentally infected with the above WHV7
serum pool (Hansen et al., 1993); in a further study, all 55
tumors were obtained from 13 animals inoculated with
WHV7P1 (Jacob et al., 2004), an inoculum consisting of
serum pooled from four chronic carriers experimentally
infected with WHV7 as newborns (Cote et al., 2000).
An aim of the present study was to evaluate the possible
influence of animal origin and mode of infection on the
frequency of WHV integration nearby N-myc2 and transcrip-
tional activation of this gene in woodchuck liver tumors, by
comparing our data from naturally infected wild woodchucks
with previously published results from experimentally infected
colony born animals. A summary of data from present and
previous studies is reported in Table 3.
Data from the study by Fourel et al. (1990) were included in
Table 3 for completeness but could not be compared with data
from wild woodchucks of the present study because mode of
infection (natural or experimental) and origin of animals (wild
or colony born) were not reported.
As explained in Results section, in the study by Jacob et al.
(2004), search for WHV integration in N-myc genes was
carried out by HindIII digestion, thus excluding an important
clustering region of WHV integration upstream of the HindIII
site 5V of the gene and likely resulting in underestimation of
total N-myc rearrangements. To carry out rigorous comparison
with data from Jacob et al. (2004), we compared data obtained
from our tumor survey by the same approach, i.e., HindIII
digestion (see HindIII column in Table 2). The frequency of N-
myc rearrangements in tumors from wild animals was found to
be somewhat lower than in Jacob et al. (2004) (13/53, 25% vs.
23/55, 43%), without reaching, however, statistical signifi-
cance. We interpreted this result as weakly suggesting that
tumors from naturally infected animals may have a lower
tendency to harbor WHV integration nearby N-myc genes than
tumors from experimentally infected animals. Further compar-
isons were not possible because, due to the aims of their study,
Jacob et al. (2004) did not distinguish if N-myc1 or N-myc2
was involved and, in addition, N-myc2 transcription was not
analyzed.
The remaining two previous studies reported more abundant
data from experimentally infected animals to be compared with
our results from wild animals, including N-myc2 transcription
data (Hansen et al., 1993; Wei et al., 1992). Comparison of data
from individual studies gave conflicting results (Table 3): in
tumors from our wild animals, the frequencies of (i) total
rearrangements in N-myc genes, (ii) WHV integration nearby
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insertion nearby the gene were similar to those reported in
Hansen et al. (1993) but showed statistically significant
differences with respect to data from Wei et al. (1992). These
conflicting results were likely due to random sampling errors
because of the small size of the tumor groups from
experimentally infected animals. In order to compare our
results with as large as possible a tumor group from
experimentally infected animals, data from Wei et al. (1992)
and Hansen et al. (1993) were combined and reported in Table
3 as a separate row labeled ‘‘Cumulative data from experi-
mentally infected animals’’. Obviously, data from Fourel et al.
(1990) and Jacob et al. (2004), for regions described above,
could not be included in this group.
As shown in Table 3, in liver tumors from the present
study, the N-myc1 gene appears to be targeted by WHV
insertion at a similar low frequency as in experimentally
infected animals (1/53, 2% vs. 1/31, 3%). In contrast, despite
a frequency of N-myc2 transcriptional activation not sub-
stantially different between the two groups (28/40, 70% vs.
20/26, 77%), the frequency of WHV integration nearby N-
myc2 in naturally infected woodchucks was found to be
lower than in experimentally infected animals (17/53, 32%
vs. 16/31, 52%), a difference not reaching statistical signifi-
cance but consistent with the findings from comparison with
data from Jacob et al. (2004) (see above), suggesting a
tendency of N-myc2 activation in wild woodchucks to be less
frequently due to WHV integration nearby the gene.
Insertions were roughly equally distributed 5V and 3V of the
N-myc2 gene, in contrast with previous studies but without
reaching statistical significance.
The above comparisons were carried out between tumor
groups including tumors both with and without N-myc2
transcriptional activation. In order to better evaluate the
possibility that N-myc2 activation in wild woodchucks might
be less frequently due to WHV integration nearby the gene than
in experimentally infected animals, we restricted comparison to
only tumors with assessed N-myc2 transcriptional activation
(last column on the right in Table 3). In this case, WHV
insertion nearby the gene was found to be quite lower in our
tumor survey than in tumors from experimentally infected
animals (12/28, 43% vs. 15/20, 75%), and the difference was
statistically significant (P = 0.0397 with Fisher’s Exact Test).
On the whole, the above comparisons show that some
differences indeed exist between tumors from naturally and
experimentally infected woodchucks: (i) the frequency of
WHV integration nearby N-myc2 in tumors from naturally
infected animals has a tendency to be lower than in
experimentally infected woodchucks, and (ii) in tumors from
naturally infected woodchucks, N-myc2 activation is due to
WHV insertion nearby the gene less frequently than in tumors
from experimentally infected animals. We propose that the
higher frequencies in experimentally infected animals may be
related to the more uniform conditions as to infecting virus and
host genetic background and, thus, that viral and/or host factors
may influence the site of viral insertion finally detected in liver
tumors, possibly by affecting either the integration steps or thepost-integration selective processes occurring in the tissue
environment during tumor development or both.
The use of standard inocula and colony born laboratory bred
animals greatly contributes to reduce experimental variability
and to enhance experimental reproducibility of in vivo studies;
however, experimental conditions also introduce some bias in
biological processes. Indeed, the existence of inoculum-
specific biological properties is documented by evidence that
inocula of the WHV7 lineage (WHV7 and WHV7P1) exhibit
chronicity rates significantly higher than inocula of another
lineage (WHV8) (Cote et al., 2000). In addition, the use of
colony born laboratory bred animals, even though not inbred,
results obviously in animals with a more homogeneous host
genetic background than wild animals. These observations
provide a rationale and give support to the above proposal.
Another aim of the present study was to evaluate if WHV
insertion in the b3n and win loci would account for N-myc2
activation in woodchuck liver tumors actively transcribing N-
myc2 in absence of any detectable alteration of the gene, as
proposed upon discovery of the b3n and win loci. Since in our
tumor survey, we found N-myc2 transcriptional activation to be
due to WHV integration nearby N-myc2 in 43% liver tumors
only, we expected frequent WHV integration in the b3n and
win loci in the remaining tumors. In contrast, results showed
that the b3n and win loci were targeted rarely. These findings
challenge the notion that N-myc2 activation is due to WHV
integration either in b3n or in win in tumors without insertion
nearby N-myc2. At least in tumors from wild woodchucks, this
notion appears to be incorrect: a considerable fraction (39%) of
liver tumors with activated N-myc2 transcription does not show
rearrangement either nearby the N-myc2 gene or in the
downstream b3n and win regions. The possibility that N-
myc2 activation in this latter tumor subgroup might have been
induced by exposure to other carcinogenic factors is unlikely
because no liver tumors at all were observed in WHV
uninfected control woodchucks, reared in the same laboratory
environment and delivered each year together with chronically
infected animals, evidence for no exposure to further liver
carcinogens other than WHV.
In tumors lacking WHV insertion both nearby N-myc2 and
in the b3n and win loci, the mechanisms underlying the
observed N-myc2 activation remain to be determined and
several explanations are possible.
Previous observations suggested that N-myc2 might be also
activated by mechanisms unrelated to WHV integration. N-
myc2 expression has been detected in nearly all altered hepatic
foci (AHFs), considered to be pre-cancerous lesions in
woodchuck liver (Yang et al., 1993). In the great majority of
AHFs, the N-myc2 expression level was somewhat lower than
in fully developed HCCs, although a small subset of AHFs was
also observed expressing high levels N-myc2 transcripts. The
estimated high number of N-myc2 expressing AHFs per liver
(exceeding 1500 per liver) (Yang et al., 1993) favors a
hypothesis of underlying mechanism(s) unrelated to WHV
integration. Support for this hypothesis has been provided by in
vitro studies in human hepatoma cell lines, reporting that the
viral X protein (pX) might collaborate with cellular factors to
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authors of this latter study suggested that pX trans-activation
might explain the weak N-myc2 expression observed at pre-
neoplastic stage but not over-expression observed in overt liver
tumors, we speculate that mutated aberrant pX versions, as
those observed in some HBV related human HCCs (Wang et
al., 2004), might show altered properties and play a role as
stronger N-myc2 trans-activator than wild-type pX in AHFs
expressing high levels N-myc2 and at least in a fraction of
HCCs.
Alternatively, since WHV integration somewhere in cellular
DNA was clearly detected in all tumors characterized by N-
myc2 activation in absence of WHV integration nearby N-myc2
and in the b3n and win loci, WHV integration might activate
one or more cellular genes, whose products might be
responsible for activating in trans the N-myc2 gene.
Finally, a further possibility is that WHV DNA might be
inserted at further sites of the N-myc2 chromosomal domain,
outside the genomic restriction fragments analyzed by
Southern blotting, either upstream or downstream of the
N-myc2 gene and either clustered in additional small regions
or scattered along the N-myc2 chromosomal domain. Indeed,
our current knowledge of the clustered distribution of WHV
insertions at defined regions along the N-myc2 chromosomal
domain in woodchuck liver tumors might also prove to be
the result of a combination of both technical limitations of
the applied investigation methods and an inherent higher
propensity of experimentally infected animals, from which
most previous data have been obtained, to develop tumors
with activated N-myc2 due to WHV integration nearby the
gene.
Further studies of the mechanisms underlying activation of
N-myc2 in woodchuck liver tumors, including the study of the
distribution of WHV integrations along the N-myc2 chromo-
somal domain, should help to clarify basic molecular mechan-
isms, operating in vivo, that could also play a role in activation
of cellular genes by HBV integration (Minami et al., 2005;
Murakami et al., 2005; Paterlini-Bre´chot et al., 2003) in HBV
induced human liver cancer too.
Materials and methods
Woodchucks and tissues
All woodchucks (M. monax) were wild-caught chronic
WHV carriers, whose WHV infection had been acquired by
natural routes. They were maintained in isolation in an animal
facility at Istituto Superiore di Sanita`, Rome, Italy, and received
humane care in compliance with the guidelines of the Italian
Ministry of Health.
Most woodchucks were purchased from International
Animal Exchange Inc. (Ferndale, MI, USA): they were
delivered in 1986 (W401/86), in 1989 (W593/89, W594/89,
W595/89, W596/89, W598/89, W212/89), in 1990 (W326/90),
in 1991 (W423/91, W426/91), in 1992 (W558/92, W596/92,
W589/92), in 1993 (W863/93, W870/93, W891/93, W899/93),
and in 1995 (W385/95, W467/95, W477/95, W481/95). Threefurther woodchucks were purchased from North Eastern
Wildlife Inc. (South Plymouth, NY, USA) in 1998 (W2177/
98, W2231/98, W2234/98).
Plasma was constantly WHV-DNA-positive in all animals,
as detected by dot-blot hybridization of follow-up samples,
except transient decline to low or undetectable level during
short-term antiviral treatments in the frame of studies about
anti-HBV drugs in eight woodchucks (W863/93, W870/93,
W891/93, W899/93, W385/95, W467/95, W477/95, W481/95)
(Fiume et al., 1995, 1997; Zahm et al., 1998). In these studies,
fast rebound of viremia at pre-treatment or close to pre-
treatment levels was observed in all responding animals when
therapy stopped.
One animal (W598/89) was subjected to an experimental
super-infection procedure with Hepatitis Delta Virus (HDV) by
in vivo liver transfection with a recombinant plasmid contain-
ing three head-to-tail cDNA copies of HDV genome. The
animal showed evidence of HDV infection (Ciccaglione et al.,
1993).
No liver tumor was observed at autopsy in uninfected
woodchucks delivered with each group of infected animals and
reared in the same laboratory environment.
Liver and tumor tissues were resected at autopsy. Tissue
fragments for histological analysis were fixed in 10% buffered
formaldehyde, embedded in paraffin, sectioned, and stained.
Aliquots of tumor and adjacent non-tumor tissues for DNA and
RNA analysis were quickly frozen in liquid nitrogen and stored
at 80 -C.
Histopathologic examination of tumor and non-tumor liver
tissues
Histologic sections of tumor and non-tumor specimens were
stained with hematoxylin–eosin. The tumor histologic grade
was determined according to Edmonson–Steiner classification,
based on cytological and architectural features (Edmonson and
Steiner, 1954).
DNA extraction and Southern blotting
DNA was extracted from non-neoplastic liver and tumor
tissues by a previously described procedure, involving incu-
bation of homogenized tissue in the presence of Proteinase K/
SDS followed by phenol/chloroform extraction and ethanol
precipitation (Bruni et al., 1995a). Purified genomic DNA was
digested with restriction enzymes (Roche) according to the
manufacturer’s instructions. Digested DNA (10 Ag) was
electrophoresed onto agarose gel, then transferred onto
positively charged nylon membrane (Zeta Probe GT, Bio-
Rad), according to the manufacturer’s instructions.
RNA extraction and Northern blotting
Total RNA was extracted from normal liver and tumor
tissues by means of the RNeasy Total RNA Kit (QIAGEN),
according to the manufacturer’s instructions. Extracted RNA
was run in formaldehyde/agarose denaturing gel, then trans-
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procedures (Sambrook et al., 1989).
Labeling and hybridization
Probes were labeled with [a32P]-dCTP with the High Prime
DNA labeling kit (Roche) according to the manufacturer’s
instructions. Filters were hybridized with 32P-labeled probes by
standard procedures (Sambrook et al., 1989).
Washing of Southern filters always included a final stringent
washing in 0.1  SSC/0.5% SDS for 30 to 60 min at 65 -C,
until decrease of background signals at acceptable levels.
Hybridization of Northern filters was carried out in 50%
deionized formamide at 42 -C (Sambrook et al., 1989); after two
washings at low stringency, a final stringent washing in 0.2 
SSC, 0.1% SDS at 65 -C for 30 min was carried out.
After autoradiographic film exposure (BioMax MS films,
Kodak), filters were stripped and/or allowed to undergo natural
decay. Loss of detectable signals was assessed by extended
autoradiography exposure before hybridization with a further
probe. Co-hybridization of DNA or RNA molecules with
multiple probes was assessed by searching for overlapping
signals in autoradiographs obtained from the same filter with
different probes. In order to identify overlapping signals
unambiguously, the faint background images of the whole
filter visible after proper exposure as well as reference points
visible in all images were exactly aligned.
Probes
Most probes (5VN-myc, N-mycGR, SpIntI, b3n and WHV)
were described in detail previously.
The position of N-myc probes is schematically reported in
Fig. 2; they detect the same HindIII and BglII woodchuck
genomic fragments investigated for WHV insertion in previous
reports (Fourel et al., 1990; Wei et al., 1992; Hansen et al.,
1993; Jacob et al., 2004). The 5VN-myc probe spans the 5V
region of N-myc2 gene (nucleotides 123 to 466 in the N-myc2
sequence Acc. no.X53671) and was amplified by PCR from
woodchuck genomic DNA (Bruni et al., 1999) by primers
reported previously (Hansen et al., 1993). The N-mycGR probe
spans the region 1156–1696 in the N-myc2 sequence (Bruni et
al., 1999). The SpIntI probe is specific for the N-myc1 gene
because spans one half of exon 1 as well as a fragment of the
first intron of N-myc1: both regions lack in the N-myc2 gene
(Fourel et al., 1990); this probe was kindly provided by Dr. M.
A. Buendia.
The b3n probe spans the region 735 to 1278 of the b3n
sequence (Acc. no. M60765) (Bruni et al., 1999).
The E850s probe was amplified by PCR with specific
primers from the pW1 plasmid, containing a 17-kb insert of the
wild-type win allele, encompassing the major region of WHV
insertion in win. pW1 was a kind gift from Dr. M. A. Buendia.
The E850s probe spans the region 15358–16173 of the
sequenced pW1 insert (Acc. no. AY173019), as confirmed by
direct sequencing with the same primers used in PCR. E850s
probe includes most of the E850 probe described previously,but is slightly smaller; it detects the same 16-kb SacI fragment
from the win locus detected by E850 (Fourel et al., 1994).
The WHV probe is a cloned full-length WHV genome and
was previously described (Bruni et al., 1995b); it was prepared
from the pW8 plasmid, a kind gift from Dr. J. Summers and Dr.
J. Pugh.
The h-actin probe was an amplified PCR product from
human genomic DNA, and spans a nucleotide region (position
86 to 311 in the human sequence Acc. no. X00351) conserved
among human, rat, hamster and mouse (89–93% homology).
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